European partnership against antibiotic resistance to be launched

The last two years include a new regional policy charter and dedicated Nordic women's health innovation hub introduced in our region.

In a region celebrated for gender equality, the life science sector tells a different story: women dominate the workforce in many jobs yet remain sidelined in leadership, funding, and research – with consequences that ripple across public health and economic performance.

Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles to allow the patient's own body to generate cell therapies that can treat underlying disease.

Innovent Biologics has announced a strategic collaboration with Eli Lilly and Company ("Lilly") to advance novel medicines in oncology and immunology.

Sweden’s updated “samverkansregler” governing collaboration between healthcare and industry took effect on 1 February 2026, following a revised national agreement between SKR (Swedish Association of Local Authorities and Regions) and the trade organisations Lif, Swedish Medtech, SwedenBIO and Swedish Labtech.

AstraZeneca has entered a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple next-generation therapies for obesity and type 2 diabetes across eight programmes.

This investment will expand medicines manufacturing and R&D in China and leverage the country’s scientific excellence, advanced manufacturing, and China-UK healthcare ecosystem collaborations.